REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT05551793 updates: 1. completion date: 2027-11-03 → 2028-10-31 2. primary completion date: 2027-11-03 → 2027-11-30 3. enrollment: 68 → 76 participants
Clinical trial NCT05551793 updates: 1. completion date: 2027-11-03 → 2028-10-31 2. primary completion date: 2027-11-03 → 2027-11-30 3. enrollment: 68 → 76 participants
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical